TY - JOUR
T1 - Progressive liver, kidney, and heart degeneration in children and adults affected by TULP3 mutations
AU - Genomics England Research Consortium
AU - Devane, John
AU - Ott, Elisabeth
AU - Olinger, Eric G.
AU - Epting, Daniel
AU - Decker, Eva
AU - Friedrich, Anja
AU - Bachmann, Nadine
AU - Renschler, Gina
AU - Eisenberger, Tobias
AU - Briem-Richter, Andrea
AU - Grabhorn, Enke Freya
AU - Powell, Laura
AU - Wilson, Ian J.
AU - Rice, Sarah J.
AU - Miles, Colin G.
AU - Wood, Katrina
AU - Trivedi, Palak
AU - Hirschfield, Gideon
AU - Pietrobattista, Andrea
AU - Wohler, Elizabeth
AU - Mezina, Anya
AU - Sobreira, Nara
AU - Agolini, Emanuele
AU - Maggiore, Giuseppe
AU - Dahmer-Heath, Mareike
AU - Yilmaz, Ali
AU - Boerries, Melanie
AU - Metzger, Patrick
AU - Schell, Christoph
AU - Grünewald, Inga
AU - Konrad, Martin
AU - König, Jens
AU - Schlevogt, Bernhard
AU - Sayer, John A.
AU - Bergmann, Carsten
N1 - Funding Information:
E.G.O. is supported by the Swiss National Science Foundation (P2ZHP3_195181 and P500PB_206851) and Kidney Research UK (Paed_RP_001_20180925). E.D. A.F. N.B. G.R. and T.E. are employees of the Medizinische Genetik Mainz. S.J.R. is funded by a Versus Arthritis career development fellowship (22615). J.A.S. is funded by Kidney Research UK, the Northern Counties Kidney Research Fund, and the Medical Research Coucil (CiC award). C.B. receives support from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) (BE 3910/8-1, BE 3910/9-1) and Collaborative Research Center SFB 1453 (project ID: 431984000) and the Federal Ministry of Education and Research (BMBF, 01GM1903I and 01GM1903G). C.B. was also supported by the Collaborative Research Center SFB 1140 (project ID: 246781735). M.B. is supported by the DFG (SFB1453 [project S1], SFB1479 [project ID: 441891347-S1], SFB1160 [Project Z02], and TRR167 [Project Z01]). M.B. and P.M. are supported by the German Federal Ministry of Education and Research by MIRACUM within the Medical Informatics Funding Scheme (FKZ 01ZZ1801B). This research was made possible through access to the data and findings generated by the 100,000 Genomes Project. The 100,000 Genomes Project is managed by Genomics England Limited (a wholly owned company of the Department of Health and Social Care). The 100,000 Genomes Project is funded by the National Institute for Health Research and NHS England. The Wellcome Trust, Cancer Research UK, and the Medical Research Council have also funded research infrastructure. The 100,000 Genomes Project uses data provided by participants and their families and collected by the National Health Service as part of their care and support. A full list of members of the Genomics England Research Consortium and their affiliations are available in the supplemental information. E.D. A.F. N.B. G.R. and T.E. are employees of Medizinische Genetik Mainz. C.B. is an employee and managing director of Medizinische Genetik Mainz and Limbach Genetics GmbH. All other authors declare no competing interests.
Funding Information:
E.G.O. is supported by the Swiss National Science Foundation ( P2ZHP3_195181 and P500PB_206851 ) and Kidney Research UK ( Paed_RP_001_20180925 ). E.D., A.F., N.B., G.R., and T.E. are employees of the Medizinische Genetik Mainz. S.J.R. is funded by a Versus Arthritis career development fellowship (22615). J.A.S. is funded by Kidney Research UK, the Northern Counties Kidney Research Fund , and the Medical Research Coucil (CiC award). C.B. receives support from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) ( BE 3910/8-1 , BE 3910/9-1 ) and Collaborative Research Center SFB 1453 (project ID: 431984000 ) and the Federal Ministry of Education and Research (BMBF, 01GM1903I and 01GM1903G ). C.B. was also supported by the Collaborative Research Center SFB 1140 (project ID: 246781735 ). M.B. is supported by the DFG ( SFB1453 [project S1], SFB1479 [project ID: 441891347-S1], SFB1160 [Project Z02], and TRR167 [Project Z01]). M.B. and P.M. are supported by the German Federal Ministry of Education and Research by MIRACUM within the Medical Informatics Funding Scheme ( FKZ 01ZZ1801B ). This research was made possible through access to the data and findings generated by the 100,000 Genomes Project. The 100,000 Genomes Project is managed by Genomics England Limited (a wholly owned company of the Department of Health and Social Care). The 100,000 Genomes Project is funded by the National Institute for Health Research and NHS England. The Wellcome Trust, Cancer Research UK, and the Medical Research Council have also funded research infrastructure. The 100,000 Genomes Project uses data provided by participants and their families and collected by the National Health Service as part of their care and support. A full list of members of the Genomics England Research Consortium and their affiliations are available in the supplemental information .
Publisher Copyright:
© 2022 The Author(s)
PY - 2022/5/5
Y1 - 2022/5/5
N2 - Organ fibrosis is a shared endpoint of many diseases, yet underlying mechanisms are not well understood. Several pathways governed by the primary cilium, a sensory antenna present on most vertebrate cells, have been linked with fibrosis. Ciliopathies usually start early in life and represent a considerable disease burden. We performed massively parallel sequencing by using cohorts of genetically unsolved individuals with unexplained liver and kidney failure and correlated this with clinical, imaging, and histopathological analyses. Mechanistic studies were conducted with a vertebrate model and primary cells. We detected bi-allelic deleterious variants in TULP3, encoding a critical adaptor protein for ciliary trafficking, in a total of 15 mostly adult individuals, originating from eight unrelated families, with progressive degenerative liver fibrosis, fibrocystic kidney disease, and hypertrophic cardiomyopathy with atypical fibrotic patterns on histopathology. We recapitulated the human phenotype in adult zebrafish and confirmed disruption of critical ciliary cargo composition in several primary cell lines derived from affected individuals. Further, we show interaction between TULP3 and the nuclear deacetylase SIRT1, with roles in DNA damage repair and fibrosis, and report increased DNA damage ex vivo. Transcriptomic studies demonstrated upregulation of profibrotic pathways with gene clusters for hypertrophic cardiomyopathy and WNT and TGF-β signaling. These findings identify variants in TULP3 as a monogenic cause for progressive degenerative disease of major organs in which affected individuals benefit from early detection and improved clinical management. Elucidation of mechanisms crucial for DNA damage repair and tissue maintenance will guide novel therapeutic avenues for this and similar genetic and non-genomic diseases.
AB - Organ fibrosis is a shared endpoint of many diseases, yet underlying mechanisms are not well understood. Several pathways governed by the primary cilium, a sensory antenna present on most vertebrate cells, have been linked with fibrosis. Ciliopathies usually start early in life and represent a considerable disease burden. We performed massively parallel sequencing by using cohorts of genetically unsolved individuals with unexplained liver and kidney failure and correlated this with clinical, imaging, and histopathological analyses. Mechanistic studies were conducted with a vertebrate model and primary cells. We detected bi-allelic deleterious variants in TULP3, encoding a critical adaptor protein for ciliary trafficking, in a total of 15 mostly adult individuals, originating from eight unrelated families, with progressive degenerative liver fibrosis, fibrocystic kidney disease, and hypertrophic cardiomyopathy with atypical fibrotic patterns on histopathology. We recapitulated the human phenotype in adult zebrafish and confirmed disruption of critical ciliary cargo composition in several primary cell lines derived from affected individuals. Further, we show interaction between TULP3 and the nuclear deacetylase SIRT1, with roles in DNA damage repair and fibrosis, and report increased DNA damage ex vivo. Transcriptomic studies demonstrated upregulation of profibrotic pathways with gene clusters for hypertrophic cardiomyopathy and WNT and TGF-β signaling. These findings identify variants in TULP3 as a monogenic cause for progressive degenerative disease of major organs in which affected individuals benefit from early detection and improved clinical management. Elucidation of mechanisms crucial for DNA damage repair and tissue maintenance will guide novel therapeutic avenues for this and similar genetic and non-genomic diseases.
KW - ciliopathy
KW - genetic disease burden
KW - hypertrophic cardiomyopathy
KW - internal medicine genetics
KW - kidney failure
KW - liver fibrosis
KW - organ fibrosis
KW - tubby-like proteins
UR - http://www.scopus.com/inward/record.url?scp=85129662559&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85129662559&partnerID=8YFLogxK
U2 - 10.1016/j.ajhg.2022.03.015
DO - 10.1016/j.ajhg.2022.03.015
M3 - Article
C2 - 35397207
AN - SCOPUS:85129662559
SN - 0002-9297
VL - 109
SP - 928
EP - 943
JO - American journal of human genetics
JF - American journal of human genetics
IS - 5
ER -